The International journal of pharmacy practice · 2026
Accuracy of tablet splitting for paediatric dosing: mass and content uniformity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hodkinson Claire, Edge Mike, Kelly Grant, White Peter, Mulla Hussain
Аннотация
OBJECTIVES: To evaluate the accuracy of tablet splitting for paediatric dosing by assessing mass and content uniformity.
METHODS: Whole, half, and quarter tablets of mercaptopurine, azathioprine, and spironolactone were prepared using a manual tablet splitter. Fragment mass and quarter-tablet drug content were assessed against European Pharmacopoeia criteria.
KEY FINDINGS: Split fragments showed high variability (coefficient of variation 8.6%-23.3%). Most failed European Pharmacopoeia mass uniformity criteria. Content analysis revealed only 50%-70% of quarters complied with acceptance limits, with ranges of 52%-133% of claim.
CONCLUSIONS: Tablet splitting introduces substantial dose variability undetectable by weighing alone. Where possible, low-strength tablets or alternative formulations should be preferred.
METHODS: Whole, half, and quarter tablets of mercaptopurine, azathioprine, and spironolactone were prepared using a manual tablet splitter. Fragment mass and quarter-tablet drug content were assessed against European Pharmacopoeia criteria.
KEY FINDINGS: Split fragments showed high variability (coefficient of variation 8.6%-23.3%). Most failed European Pharmacopoeia mass uniformity criteria. Content analysis revealed only 50%-70% of quarters complied with acceptance limits, with ranges of 52%-133% of claim.
CONCLUSIONS: Tablet splitting introduces substantial dose variability undetectable by weighing alone. Where possible, low-strength tablets or alternative formulations should be preferred.